PB
Pacira BioSciences, Inc.
🇺🇸XNAS.PCRXUnited StatesHealthcare
$24.89USDup +0.81 (+3.36%)ClosedDelayed5:41 AM
Price$24.89+0.81 (+3.36%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US6951271005
- CUSIP
- 695127100
Company
- Employees
- 825
- Headquarters
- Brisbane, United States
- Website
- https://www.pacira.com
- CEO
- Mr. Frank D. Lee
Market
- Shares outstanding
- 39.9M
- Market cap
- $992.16M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $992.16M
- EPS LTM
- $0.37calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 67.78calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $746.16M+5.71%up year on year
- Net income
- $14.64M+111.48%up year on year
- Gross margin
- 79.21%+1.3%up year on year
- Free cash flow
- $179.52M+53.34%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.